Valuation: Circio Holding ASA

Market Cap 1.89B 192M 168M 154M 144M 271M 18.33B 277M 1.85B 720M 8.98B 723M 707M 30.98B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.89B 193M 168M 154M 144M 271M 18.35B 277M 1.85B 721M 8.99B 724M 708M 31.02B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+4.89%
1 week+3.79%
Current month+7.73%
1 month-6.70%
3 months-26.48%
6 months+550.82%
Current year+582.13%
1 week 7.17
Extreme 7.17
8.17
1 month 6.94
Extreme 6.94
8.77
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
248.4
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/11/21Fiscal year

Chief Executive Officer

120,000 0.1386%
19/05/21Buy

Director

21,299 0.0246%
03/12/20Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+4.89%+3.79%+1,160.32%-53.57% 183M
+0.68%+6.27%+77.60%+133.76% 58.73B
+2.32%+5.89%+76.81%+99.20% 53.92B
+3.86%+8.38%-9.90%-9.62% 24.67B
+4.30%+6.82%+13.60%+428.91% 24.19B
+4.74%+13.47%+46.43%+0.03% 18.8B
-0.29%+8.57%+44.17%-27.58% 17.61B
0.00%+16.74%+171.12%+355.99% 16.25B
+3.50%+4.92%+26.07%+192.26% 14.04B
+6.72%+20.94%+51.67% - 13.9B
Average +3.07%+6.34%+165.79%+124.37% 24.23B
Weighted average by Cap. +2.44%+5.52%+59.90%+137.19%

Financials

2024 2025
Net sales - -
Net income 57.52M 5.86M 5.11M 4.68M 4.38M 8.24M 558M 8.42M 56.31M 21.92M 273M 21.99M 21.51M 943M -45.91M -4.68M -4.08M -3.74M -3.49M -6.58M -445M -6.72M -44.94M -17.49M -218M -17.55M -17.17M -753M
Net Debt -972K -98.99K -86.38K -79.14K -73.98K -139K -9.42M -142K -951K -370K -4.62M -372K -364K -15.93M 2.24M 229K 200K 183K 171K 322K 21.77M 329K 2.2M 855K 10.67M 858K 840K 36.8M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
03/07/26 NOK 7.940 +4.89% 5,609,934
02/07/26 NOK 7.570 +2.16% 3,404,702
01/07/26 NOK 7.410 +0.54% 1,998,140
30/06/26 NOK 7.370 -1.07% 4,280,344
29/06/26 NOK 7.450 -2.10% 3,324,258

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock